Antiarrhythmic drug-induced internalization of the atrial-specific k+ channel kv1.5.
about
Role for myosin-V motor proteins in the selective delivery of Kv channel isoforms to the membrane surface of cardiac myocytesShear stress triggers insertion of voltage-gated potassium channels from intracellular compartments in atrial myocytes.Antidepressant-induced ubiquitination and degradation of the cardiac potassium channel hERG.Over-expression of microRNA-1 causes arrhythmia by disturbing intracellular trafficking system.Open channel block of Kv1.5 currents by citalopram.Inhibition of UV-B induced apoptosis in corneal epithelial cells by potassium channel modulators.Auranofin protects against anthrax lethal toxin-induced activation of the Nlrp1b inflammasomeEmerging concepts in the pharmacogenomics of arrhythmias: ion channel trafficking.Ion channel trafficking: a new therapeutic horizon for atrial fibrillationKv1.3: a potential pharmacological target for diabetes.Involvement of Kv1.5 protein in oxidative vascular endothelial cell injuryImproved functional expression of human cardiac kv1.5 channels and trafficking-defective mutants by low temperature treatmentNovel pharmacological targets for the rhythm control management of atrial fibrillation.Polycomb-dependent repression of the potassium channel-encoding gene KCNA5 promotes cancer cell survival under conditions of stressDelayed endosome-dependent CamKII and p38 kinase signaling in cardiomyocytes destabilizes Kv4.3 mRNADynamic reciprocity of sodium and potassium channel expression in a macromolecular complex controls cardiac excitability and arrhythmiaSubunit-dependent axonal trafficking of distinct alpha heteromeric potassium channel complexesTrafficking of intermediate (KCa3.1) and small (KCa2.x) conductance, Ca(2+)-activated K(+) channels: a novel target for medicinal chemistry efforts?Blockade of Kv1.5 channels by the antidepressant drug sertraline.Interaction of local anesthetics with the K (+) channel pore domain: KcsA as a model for drug-dependent tetramer stabilityNew developments in atrial antiarrhythmic drug therapy.Forward trafficking of ion channels: what the clinician needs to know.Ultra-rapid delayed rectifier channels: molecular basis and therapeutic implications.Novel molecular targets for atrial fibrillation therapy.Dynamic of ion channel expression at the plasma membrane of cardiomyocytes.Redox-sensitive sulfenic acid modification regulates surface expression of the cardiovascular voltage-gated potassium channel Kv1.5.hERG K+ channel-associated cardiac effects of the antidepressant drug desipramine.Ion Channel Trafficking: Control of Ion Channel Density as a Target for Arrhythmias?Genistein and tyrphostin AG556 decrease ultra-rapidly activating delayed rectifier K+ current of human atria by inhibiting EGF receptor tyrosine kinase.Downregulation of Kv1.5 K channels by the AMP-activated protein kinase.The Pattern of mRNA Expression Is Changed in Sinoatrial Node from Goto-Kakizaki Type 2 Diabetic Rat HeartLe cisaillement régule le trafic des canaux potassiques atriaux
P2860
Q28565984-48D9D8A5-AEE3-4DE9-A9BB-7081B9A55DBDQ30551520-129E032A-B3C9-4F73-848E-594B9FB82FD2Q33160342-6E1E5F28-A0E2-4135-90BD-6A3307FB56EAQ33551604-6A31D94F-6420-4B60-88B4-F7517A2658C2Q33557233-CED4AB7D-F46F-4591-9E44-2D3B933FEE86Q33653711-133A7872-C8E3-43E8-B23D-4785360ACE71Q33768371-9E16705C-10FD-4CC9-8910-A2565F6D2558Q34066888-C7D5B38E-C798-4088-8D1E-6E1133456371Q34101658-39F31994-0A77-479A-AA29-C838D51982F3Q34131276-F724ED68-6A0A-4867-A5D5-CB9AE68577B2Q34490473-D1E8B6E6-930D-4B5E-B641-50E2A7266D2DQ35129668-93540837-758E-4CA9-B3FA-BAD4B88FDBE5Q35489060-FDA29159-195A-40EF-81C2-8D4A28EAAF50Q35672183-EE32C717-C94D-4EC9-A540-6B7FF981789CQ35892575-FD5A1828-1D26-4122-A83E-F8F6B3BE3C3FQ36140564-69B25C8E-F5CE-45D5-A7ED-5BB16E07F0FFQ36153384-EFF482D9-7D83-400A-AF6C-912924557C1AQ36269118-3E7A4D15-4462-48F4-ABC9-C8C43807DA7CQ36627616-8DE12F07-DFCC-400A-B959-55EA0F2684D4Q37009060-E0DF5704-A9F5-49B7-A127-BD7112031313Q37697498-3EEBABC7-F775-487E-BBD9-329E021AAADEQ37771741-A06B21BB-E6C2-499D-99DD-27F85CEDE320Q37821136-167E7A73-88EC-40A1-A917-C405470282FCQ37998312-607BA177-2DAC-4B5F-A2CA-BB8C1C59B580Q38027484-678C2091-1873-4FE8-B2D8-3829E67D0184Q39306447-7EA54AF4-FE70-418C-A10D-57FB31A0A69FQ43487048-3D82C0BF-E160-474E-95CB-4EB1F355103BQ47580184-25539230-4AAF-456B-9543-44051773BCB5Q48367671-FF613CEE-510D-4717-B5F2-AC6F9CBEF918Q48634800-8A842628-4E4A-4A7D-A72E-0D56D030F3D7Q58770194-2F07F6B4-54A4-443F-9CC1-085848A3845CQ59248664-11C79BBD-F98F-4DDD-ACB7-A8F72103CA73
P2860
Antiarrhythmic drug-induced internalization of the atrial-specific k+ channel kv1.5.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Antiarrhythmic drug-induced internalization of the atrial-specific k+ channel kv1.5.
@en
Antiarrhythmic drug-induced internalization of the atrial-specific k+ channel kv1.5.
@nl
type
label
Antiarrhythmic drug-induced internalization of the atrial-specific k+ channel kv1.5.
@en
Antiarrhythmic drug-induced internalization of the atrial-specific k+ channel kv1.5.
@nl
prefLabel
Antiarrhythmic drug-induced internalization of the atrial-specific k+ channel kv1.5.
@en
Antiarrhythmic drug-induced internalization of the atrial-specific k+ channel kv1.5.
@nl
P2093
P2860
P1433
P1476
Antiarrhythmic drug-induced internalization of the atrial-specific k+ channel kv1.5.
@en
P2093
Dyke P McEwen
Jeffrey R Martens
Kristin L Arendt
Kristin M Van Genderen
Lian Zhang
Sarah M Schumacher
P2860
P304
P356
10.1161/CIRCRESAHA.108.192773
P577
2009-05-14T00:00:00Z